Clinical trial
Reverse Remodeling of the Pulmonary Vasculature: a Longitudinal, Investigational Study of the Effects of Sotatercept.
NCT07487441 is registered in ClinicalTrials.gov with Franz Rischard, DO as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Reverse Remodeling of the Pulmonary Vasculature: a Longitudinal, Investigational Study of the Effects of Sotatercept.
- Lead sponsor
- Franz Rischard, DO
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- March 15, 2026
- Completion date
- June 15, 2028
- Enrollment
- 30 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
pulmonary arterial hypertension (pah), pulmonary hypertension